Longevity Thematic ETF

Fund Summary

The Global X Longevity Thematic ETF (LNGR) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Longevity Thematic ETF (LNGR) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.


High Growth Potential

LNGR enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

LNGR's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, LNGR delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 01/21/21

Key Facts

Ticker LNGR
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 100

Stats & Fees

Net Assets $54,037,370
Net Asset Value (NAV) $29.21
Shares Outstanding 1,850,000
Total Expense Ratio 0.50%


30-Day SEC Yield 0.47%
Distribution Frequency Semi-Annually

Fund Prices As of 01/21/21

NAV $29.21 Daily Change -$0.14 -0.46%
Market Price $29.25 Daily Change -$0.12 -0.39%
30-Day Median Bid-Ask Spread 0.28%

Performance History

Cumulative %

Data as of month-end (12/31/20)

Fund NAV Market Price Index
Year-to-Date 19.28% 18.96% 19.60%
1 Month 4.68% 4.19% 4.73%
3 Months 9.41% 9.06% 9.53%
6 Months 14.97% 14.51% 15.14%
Since Inception 91.01% 94.34% 93.61%

Avg Annualized %

Data as of month-end (12/31/20)

Fund NAV Market Price Index
1 Year 19.28% 18.96% 19.60%
3 Years 13.97% 13.69% 14.21%
Since Inception 14.96% 15.39% 15.27%

Avg Annualized %

Data as of quarter-end (12/31/20)

Fund NAV Market Price Index
1 Year 19.28% 18.96% 19.60%
3 Years 13.97% 13.69% 14.21%
Since Inception 14.96% 15.39% 15.27%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Fund Characteristics As of 01/21/21

Return on Equity 11.60%
Weighted Avg. Market Cap 42,072 M
2019 2020
Price-to-earnings 36.11 34.72
Price-to-book value 4.19 3.88

Source: AltaVista Research, LLC

Fund Risk Stats As of 01/21/21

Versus Beta
S&P 500 0.86
MSCI Emg. Mkts 0.64
Standard Deviation 18.60%

Source: AltaVista Research, LLC

Sector Breakdown As of 12/31/20

% of Net Assets
Health Care 93.3
Real Estate 5.2
Information Technology 0.8
Consumer Discretionary 0.4
Industrials 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 12/31/20

% of Net Assets
United States 60.0
Denmark 6.6
Japan 6.3
Switzerland 5.2
China 4.0
South Korea 3.4
Ireland 3.2
Britain 3.2
France 2.1
Germany 1.8
Belgium 1.4
Other/Cash 2.8

Source: AltaVista Research, LLC

Top 10 Holdings As of 01/22/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.07 ABBV ABBVIE INC B92SR70 110.86 15,013 1,664,341.18
2.96 SYK STRYKER CORP 2853688 239.93 6,684 1,603,692.12
2.85 ALGN ALIGN TECHNOLOGY INC 2679204 534.08 2,885 1,540,820.80
2.81 4519 JP CHUGAI PHARMA CO 6196408 54.13 28,098 1,521,027.57
2.70 EW EDWARDS LIFESCIENCES CORP 2567116 85.52 17,087 1,461,280.24
2.68 NOVOB DC NOVO NORDISK A/S-B BHC8X90 72.74 19,955 1,451,444.90
2.61 068270 KS CELLTRION INC B0C5YV1 281.01 5,038 1,415,684.00
2.56 MDT MEDTRONIC PLC BTN1Y11 116.58 11,881 1,385,086.98
2.51 AMGN AMGEN INC 2023607 253.50 5,356 1,357,746.00
2.45 ALC SW ALCON INC BJT1GR5 73.94 17,955 1,327,536.34
Holdings are subject to change.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which LNGR may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. LNGR is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.